|
2001 2000
1999
1998 1997
1996
No meetings were held.
No meetings were held.
Date: 4/20/99
Topic: Discussion of appropriate populations and outcome measures for clinical
trials for drugs to treat alcohol use disorders.
Date: 4/27/98-4/28/98
Topic: Discussion of scientific evidence for initiating a scheduling action for
Ultram (tramadol hydrochloride).
Document Available: Transcript
Additional Documents: Agenda, Questions,
Materials 
 Back to Top
Date: 2/10/97-2/11/97
Topic: Discussion of Quit Brand silver acetate lozenges for smoking
cessation.
Topic: Soma (carisoprodol), NDA 11-792
Topic: Consideration of DEA petition regarding scheduling of
carisoprodol.
Date: 6/9-10/97
Topic: Discussion on ways to make labeling for smoking cessation products more
clinically useful and discussions on topics in clinical trial design for medications used
to treat cocaine abuse.
Date: 12/13/96
Topic: Bupropion hydrochloride sustained release tablets, NDA 20-711
Topic: Nicotrol Inhaler (nicotine inhalation system), NDA 20-724
Document Available: Agenda, Summary Minutes
Transcript can be ordered
from the Freedom of Information Office
Back to Top  Back to
Human Drug Advisory Committee Information
Last Updated: June
4, 2002 |
